OCUL
Ocular Therapeutix, Inc. (OCUL)
Last Price$7.52.7%
Market Cap$1,266.9M
Last Earnings date
Sep'24
Q3 2024
($0.29)
14.2% miss
Next quarter EPS Estimate
($0.24)
(14.3%)YoY

OCUL Earnings and Expectations

Revenue

Crunching data... Almost there!

OCUL EPS (Earnings Per Share)

Crunching data... Almost there!

OCUL Historical Revenue & EPS and Expectations

1Y
3Y
5Y
10Y
Revenue
EPS
$0.0$5,000.0K$10.0M$15.0MApr'20Jul'20Oct'20Jan'21Apr'21Jul'21Oct'21Jan'22Apr'22Jul'22Oct'22Jan'23Apr'23Jul'23Oct'23Jan'24Apr'24Jul'24Oct'24$2,609.0K$5,876.0K$7,342.0K$12.2M$13.2M$12.0M$13.4M$15.0M$14.7M$15.4M
Value Sense
Actual Revenue
Forecast Revenue

OCUL Earnings History

Mar'15Jun'15Sep'15Dec'15Mar'16Jun'16Sep'16Dec'16Mar'17Jun'17Sep'17Dec'17Mar'18Jun'18Sep'18Dec'18Mar'19Jun'19Sep'19Dec'19Mar'20Jun'20Sep'20Dec'20Mar'21Jun'21Sep'21Dec'21Mar'22Jun'22Sep'22Dec'22Mar'23Jun'23Sep'23Dec'23Mar'24Jun'24Sep'24Dec'24
Revenue actual$426.0K$459.0K$429.0K$436.0K$458.0K$441.0K$477.0K$511.0K$475.0K$438.0K$523.0K$487.0K$340.0K$648.0K$498.0K$504.0K$492.0K$650.0K$829.0K$2,256.0K$2,609.0K$1,569.0K$5,876.0K$7,349.0K$7,342.0K$11.7M$12.2M$12.3M$13.2M$12.3M$12.0M$14.1M$13.4M$15.2M$15.0M$14.8M$14.7M$16.4M$15.4M$17.1M
Revenue estimate$474.7K$474.7K$474.7K$474.7K$447.6K$447.6K$447.6K$447.6K$393.1K$393.1K$393.1K$393.1K$323.0K$323.0K$323.0K$323.0K$428.8K$738.4K$580.0K$2,195.0K$2,655.5K$1,498.8K$5,501.4K$7,730.2K$7,636.7K$10.8M$12.5M$13.9M$14.0M$14.2M$14.3M$13.5M$14.1M$14.6M$15.2M$15.7M$15.4M$15.8M$17.1M$17.2M
Revenue surprise10.3%3.3%9.6%8.1%2.3%1.5%6.6%14.2%20.8%11.4%33.0%23.9%5.3%100.6%54.2%56.0%14.7%12.0%42.9%2.8%1.8%4.7%6.8%4.9%3.9%8.2%2.4%11.7%5.5%13.9%16.2%4.0%5.1%3.8%1.8%5.7%4.2%3.7%9.9%0.4%
EPS actual($0.35)($0.45)($0.47)($0.43)($0.44)($0.46)($0.39)($0.52)($0.58)($0.64)($0.54)($0.44)($0.40)($0.37)($0.38)($0.42)($0.41)($0.57)($0.40)($0.54)($0.41)($0.64)($0.19)($1.21)$0.04($0.11)$0.03($0.07)($0.09)($0.21)($0.35)($0.15)($0.47)($0.26)($0.01)($0.35)($0.49)($0.26)($0.22)($0.29)
EPS estimate($0.43)($0.43)($0.43)($0.43)($0.42)($0.42)($0.42)($0.42)($0.38)($0.38)($0.38)($0.38)($0.36)($0.36)($0.36)($0.36)($0.41)($0.48)($0.51)($0.42)($0.37)($0.30)($0.24)($0.17)($0.21)($0.21)($0.26)($0.23)($0.23)($0.22)($0.24)($0.25)($0.26)($0.30)($0.29)($0.30)($0.19)($0.22)($0.24)($0.25)
EPS surprise18.6%4.7%9.3%0.0%4.8%9.5%7.1%23.8%52.6%68.4%42.1%15.8%11.1%2.8%5.6%16.7%0.0%19.4%21.1%28.6%10.8%113.3%21.5%626.0%119.4%47.6%111.5%69.1%62.4%5.4%46.9%40.8%78.5%13.7%97.7%18.1%154.5%17.5%9.4%14.2%

Overview of financial statements

Income statement
Balance sheet
Cash Flow statement
$17.1M 15.4% YoY
$15.9M 18.2% YoY
92.8% margin
Cost of revenue
$1,230.0K (11.3%) YoY
Operating expenses
$66.4M 98.5% YoY
Net income
$48.4M 65.6% YoY
(283.3%) margin
Other: $48.4M
R&D
$41.0M 153.1% YoY
240.0% of revenue
SG&A
$25.4M 47.3% YoY
148.9% of revenue

Competing with OCUL Earnings

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Revenue
EPS
Last quarter Revenue growth
Last quarter EPS growth
Last quarter Revenue surpriseLast quarter EPS surprise
Next quarter Revenue growth
Next quarter EPS growth
Last 10 Earnings (how many miss vs beat)
1Y Fwd Revenue growth
1Y Fwd EPS growth
$1,266.9M
$63.7M
($1.26)
15.4%
(17.1%)
Miss by 0.4%
Beat by 14.2%
(1.7%)
(9.0%)
Beats: 3
Misses: 7
9.1%
8.3%
$388.2B
DKK 290.4B
DKK 22.67
30.1%
28.9%
Beat by 7.9%
Beat by 5.9%
(6.5%)
0.4%
Beats: 5
Misses: 5
20.0%
23.2%
$125.7B
$11.0B
($2.06)
15.7%
(5.6%)
Beat by 4.5%
Miss by 11.1%
(3.9%)
23.5%
Beats: 8
Misses: 2
6.8%
(988.1%)
$76.1B
$14.2B
$40.88
10.3%
(21.6%)
Beat by 0.8%
Miss by 23.9%
(7.6%)
23.6%
Beats: 7
Misses: 3
3.4%
9.5%
$35.7B
$2,258.9M
($1.77)
73.8%
N/A
Beat by 40.1%
Miss by 281.3%
23.0%
0.7%
Beats: 8
Misses: 2
76.9%
(142.5%)
$31.4B
$2,248.2M
($2.17)
34.9%
(40.9%)
Beat by 1.6%
Beat by 27.8%
(7.3%)
14.3%
Beats: 7
Misses: 3
16.9%
(55.3%)
$26.1B
€3,040.1M
(€1.96)
39.0%
20.3%
Beat by 761.0%
Miss by 141.1%
(10.3%)
(51.6%)
Beats: 5
Misses: 5
(28.2%)
(182.9%)
$14.1B
$2,877.4M
$26.45
19.7%
45.9%
Miss by 0.5%
Beat by 2.4%
3.0%
6.7%
Beats: 5
Misses: 5
10.7%
9.9%
$13.7B
$3,229.0M
($9.29)
(65.7%)
N/A
Miss by 0.7%
Beat by 6.8%
(81.0%)
(0.1%)
Beats: 9
Misses: 1
(16.2%)
(3.3%)
$12.8B
$0.0
($0.31)
(100.0%)
62.6%
undefinedN/A
undefinedN/A
0.0%
(24.5%)
Beats:
Misses:
N/A
6.8%

FAQ

1. When was Ocular Therapeutix, Inc.'s last earnings date?

Ocular Therapeutix, Inc.'s last earnings date was Sep'24 (Q3 2024).

2. What is Ocular Therapeutix, Inc.'s EPS, and was there a surprise?

3. What is Ocular Therapeutix, Inc.'s revenue, and was there a surprise?

4. What is Ocular Therapeutix, Inc.'s next quarter EPS estimate?

Ocular Therapeutix, Inc.'s next quarter EPS estimate is ($0.24), with an expected (14.3%) YoY growth.